| Category | Eye Care / Precision Skincare |
| Founded | 2016 |
| Headquarters | Shanghai |
| Listing | Private |
| Latest revenue | No published financials |
| Hero SKUs | Smile Eye Cream |
Brand History
Founded in Shanghai in 2016 by a team with dermatology and bioinformatics backgrounds, UNISKIN began with diagnostics rather than products: skin genetic and condition assessments that drove formula recommendations — a 'diagnose first' logic rare among domestic brands. In 2019 the Smile Eye Cream, pairing eye-area anti-aging with a gentle formula, became a hit.
That success concentrated resources on eye care, later extended to facial anti-aging and sunscreen. The brand works with dermatologists and aesthetic clinics as both credibility and acquisition, while educating consumers online. In 2025 it productised diagnostics with a home skin scanner, shifting from selling products to selling regimens; as a private company it does not disclose revenue.
Hero Products
Three-Year Financials
Neither the brand nor its parent publishes audited annual financials; no estimates are provided.
Brand-level：Revenue and volumes are not disclosed; public information covers products and channels.
Source：Brand and media information (no audited data)
Company Coverage
- 2025-11Diagnostics productised
A home skin scanner brings clinic-grade assessment into the household.
Source：Brand - 2025-06Eye category extended
From cream to masks and serums, forming a full eye-care matrix.
Source：Brand - 2024-10Post-procedure regimens with clinics
Pre-assessment plus post-care targets the light-aesthetics population.
Source：Trade media
Observation: UNISKIN's diagnostics-led entry sits a layer deeper than selling products — it captures consumers' skin data. The difficulty is converting that data into repurchase: testing is infrequent, and without a loop into product iteration the device becomes a one-off hardware business. Extending the eye-care category is the more realistic growth path.